Chloe Smith is an associate in Goodwin’s Technology and Life Sciences groups in London. Ms. Smith advises clients on a broad range of corporate matters, with a focus on transactions in the life sciences, healthcare, and technology sectors. She has particular experience advising on private equity and venture capital investments/exits, mergers and acquisitions, corporate finance and reorganisations, as well as general corporate matters.

Areas of Practice
Domaines D’Expertise





M&A Transactions

  • Advised FPE Capital on the sale of its majority stake in Sohonet, the leading provider of global connectivity, media services and network security for the media and entertainment industry, to Lloyds Development Capital.
  • Advised KaNDy Therapeutics, a private clinical-stage biotech, on its sale to Bayer for $425 million upfront with up to $450 million in development milestone payments and triple digit millions in commercial milestones.
  • Advised Symprove Holdings Limited and its shareholders, on the sale of 100% of its share capital, to bd-capital for a total initial consideration of approximately £40 million. 
  • Advised Webster Equity Partners on its acquisition of Vivona Brands from Inflexion, which delivers on-trend beauty, wellbeing and lifestyle brands to global fast fashion and beauty consumers.
  • Advised Amcor on the completion of its sale of 100% of the equity in Bemis Healthcare Packaging Limited, Bemis Healthcare Packaging Ireland Limited and Bemis Elsham Limited, to Kohlberg & Company for approximately US$400 million.


  • Advised Centessa Pharmaceuticals on its initial public offering on NASDAQ which totalled £379.5 million.
  • Advised Vaccitech on its $110 million initial public offering on NASDAQ.
  • Advised COMPASS Pathways on its $146.6 million initial public offering on NASDAQ, and its $80 million crossover round. Compass is a life sciences company dedicated to accelerating patient access to evidence-based innovation in mental health.

VC Transactions

  • Advised Amadeus Capital Partners and Octopus Ventures on their series seed investment into Unlikely Artificial Intelligence Limited.
  • Advised Octopus Ventures on their series seed investment into Contingent & Future Technologies Ltd and their series A investment into Orca Computing Limited.
  • Advised Octopus Ventures and Merck Ventures on their series seed investment into NanoSyrinx Ltd.
  • Advised Lakestar on its £10.2 million series A investment into Yapily Ltd.
  • Advised Y Combinator’s Continuity growth fund as lead investor on a Series F investment of £113 million ($144 million) and its participation in a Series G investment of £60m into Monzo Bank.
  • Advised Novo Holdings A/S, a leading international life sciences investor, on its $40 million investment as part of a $60 million Series C funding round into Exscientia Limited, a world leading AI-driven drug discovery company based in the UK.
  • Advised 83North as lead investor in Podimo ApS as part of Podimo’s €15 million Series A financing.


  • Advised Centessa Pharmaceuticals on the completion of its $250 million financing round in parallel with the simultaneous acquisition by Centessa of 10 private biotech companies across 4 jurisdictions.
  • Advised Selina Finance on a $150 million series B financing round.
  • Advised Tranch on its US$4.25 million pre-seed equity and debt funding.
  • Advised Grip on its $13 million Series A financing round led by Kennet Partners.

In The News









Legal Practice Course, 2018
BPP Law School
LLB, Law with Australian Law, 2016
University of Nottingham



Solicitor of the Senior Courts of England and Wales
Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.


Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Search Other Lawyers
Recherche par Pratique